Article
The diagnostic value of comprehensive next-generation sequencing for genetic mutations in suspected lung cancer cases with negative pathological cytology.
Lung cancer (Amsterdam, Netherlands) - 1 Apr 2025
Goto Yuka, Watanabe Satoshi, Yanagimura Naohiro, Arita Masashi, Sato Miyuki, Nozaki Koichiro, Tanaka Tomohiro, Saida Yu, Maemondo Makoto, Kobayashi Kunihiko, Hagiwara Koichi, Kikuchi Toshiaki
Abstract excerpt
INTRODUCTION: In recent clinical practice, driver gene mutations have been tested using multiplex PCR or next-generation sequencing (NGS), which help determine treatment strategies for non-small cell lung cancer (NSCLC). We developed a new analysis system, the Mutation Investigator using Next-era Sequencer (MINtS), using NGS, which allows for the detection of gene mutations even in cytology specimens with low...
Read the complete abstract on PubMedTopics
- Humans
- Lung Neoplasms
- High-Throughput Nucleotide Sequencing
- Male
- Mutation
